Home » Topics » BioWorld Science

BioWorld Science
RSS

Vertex and Genomics collaborate to advance discovery of precision medicines

Aug. 30, 2018

Lenvima capsules approved for first-line treatment of HCC in South Korea

Aug. 30, 2018

Positive XEN-1101 pharmacodynamic data from Xenon's phase Ib TMS study

Aug. 30, 2018

Low levels of CDKN1C indicate LV dysfunction risk in women after myocardial infarction

Aug. 30, 2018

Duzallo, a fixed-dose combination therapy for gout, approved in Europe

Aug. 30, 2018

Merck & Co. optimizes newly discovered IDO1 inhibitors

Aug. 30, 2018

Astellas Pharma discloses KRAS Gly12Cys mutant inhibitors

Aug. 30, 2018

Phase II PANTHEON results for neladenoson bialanate in heart failure patients reported

Aug. 30, 2018

Finally, the best of both worlds? Bifunctional opioid agonist fights pain, and addiction

Aug. 30, 2018

SLC10A7 gene mutations implicated in skeletal dysplasia

Aug. 30, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...